Evaluation of Clinical and Microbial Efficacy and Safety of AzaSite Compared to Vehicle for Bacterial Conjunctivitis (C-01-401-003)
NCT00105534
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
685
Enrollment
INDUSTRY
Sponsor class
Conditions
Bacterial Conjunctivitis
Interventions
DRUG:
AzaSite
OTHER:
Vehicle
Sponsor
Merck Sharp & Dohme LLC